We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
More than a dozen countries — with the notable exception of the United States — have pledged to contribute approximately $8 billion to develop potential COVID-19 vaccines and treatments. Read More
The former director of HHS’s Biomedical Advanced Research and Development Authority (BARDA) has filed a whistleblower complaint claiming he was removed from his role as head of the federal vaccine development agency in part for pushing for a more aggressive response to COVID-19. Read More
Blood pressure medications do not increase the risk of contracting COVID-19 or of serious illness or death in COVID-19 patients as previously thought, three large observational studies showed. Read More
HHS and FEMA will control the distribution of Gilead’s remdesivir as a COVID-19 treatment as a condition of its Emergency Use Authorization (EUA) by the FDA. Read More